PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-941

Well we are all cashed up

Biotech Catalysts on the Horizon

Tablets completed Manufacturing ,, the most GMP Grade tablets ever produced in the History of the Company 1 x 250,000 primary testing run then 3 x 250,000 Commercially run Batches..

Trial Registration , well having Healey with 70 Trial Locations will accelerate

Recruitment ,,,PAA's Phase I data being so positive with Life Extension defined , recruitment should be swift with absolute Trial Patient Benefits

First Patient Dosed ,,, usually a significant catalyst that Traders identify as entry positions.

Fight MND grant approval circa $1.5m to $1.8m as well as vital funds this also lends credibility and recognition that MPL is Valuable and worth pursuing.

As always the Editorial although free does get rinsed on a daily basis from the front page of sites ,, Paid Content is the only certain way to remain current and centre page in front of investors..

Best of luck to all Holders

Michael is presenting in Sydney and Melbourne next week with RAC, CHM , SNT , IMM, BDX
11;30 Tuesday Sydney
12;45 Wednesday Melbourne

Plenty of Media Present for Michael to continue his incredible effort of exposing Pharmaust to the Medical and Investment communities
..
Tight Hands ,,, NZT